Literature DB >> 20108050

Serum phospholipid transfer protein activity after a high fat meal in patients with insulin-treated type 2 diabetes.

Axel Schlitt1, Bernhard Schwaab, Kirsten Fingscheidt, Karl J Lackner, Gunnar H Heine, Alexander Vogt, Michael Buerke, Lars Maegdefessel, Uwe Raaz, Karl Werdan, Xian-Cheng Jiang.   

Abstract

Plasma phospholipid transfer protein (PLTP) mediates both net transfer and exchange of phospholipids between different lipoproteins. Animal studies have shown that it is closely related to the development of atherosclerosis. Although many studies have indicated that PLTP activity is increased in diabetes mellitus, the role of PLTP in diabetes is still unclear. To evaluate the influence of a high-fat meal on PLTP activity, 50 nondiabetic patients with coronary heart disease (CHD), 50 insulin-treated Type 2 diabetics, and 50 healthy controls were included. We determined PLTP activity before and 4 and 8 h after a high-fat meal. As expected, serum PLTP activity was significantly higher in CHD patients than in healthy controls (71.0 +/- 46.2 vs. 54.0 +/- 33.8 pmol/microl/h, P = 0.032) at baseline. More importantly, we found that serum PLTP activity increased to its maximum 4 h after fat loading and then decreased to nearly basal levels after 8 h both in controls and CHD patients. In contrast, PLTP activity continuously increased during this time period in the diabetic patients. With regards to the data from this study we hypothesize that serum PLTP is involved in the clearance of postprandial lipoproteins and this process is attenuated in diabetes. Since postprandial lipoproteins are atherogenic, the delay in clearance of these particles could play an important role in the development of atherosclerosis in patients with diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20108050     DOI: 10.1007/s11745-010-3384-5

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  30 in total

Review 1.  Insulin resistance and cardiovascular disease.

Authors:  S I McFarlane; M Banerji; J R Sowers
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Elevated plasma phospholipid transfer protein activity is a determinant of carotid intima-media thickness in type 2 diabetes mellitus.

Authors:  R de Vries; G M Dallinga-Thie; A J Smit; B H R Wolffenbuttel; A van Tol; R P F Dullaart
Journal:  Diabetologia       Date:  2005-12-23       Impact factor: 10.122

3.  Acute and chronic effects of a 24-hour intravenous triglyceride emulsion challenge on plasma lecithin: cholesterol acyltransferase, phospholipid transfer protein, and cholesteryl ester transfer protein activities.

Authors:  S C Riemens; A Van Tol; W J Sluiter; R P Dullaart
Journal:  J Lipid Res       Date:  1999-08       Impact factor: 5.922

4.  Elevated plasma cholesteryl ester transfer in NIDDM: relationships with apolipoprotein B-containing lipoproteins and phospholipid transfer protein.

Authors:  S Riemens; A van Tol; W Sluiter; R Dullaart
Journal:  Atherosclerosis       Date:  1998-09       Impact factor: 5.162

5.  Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels.

Authors:  X C Jiang; C Bruce; J Mar; M Lin; Y Ji; O L Francone; A R Tall
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

6.  Human plasma phospholipid transfer protein activity is decreased by acute hyperglycaemia: studies without and with hyperinsulinaemia in Type 1 diabetes mellitus.

Authors:  P H N Oomen; A van Tol; H Hattori; A J Smit; L M Scheek; R P F Dullaart
Journal:  Diabet Med       Date:  2005-06       Impact factor: 4.359

7.  Lipid transfer protein activities in subjects with impaired glucose tolerance.

Authors:  Ulrich Julius; Matti Jauhiainen; Christian Ehnholm; Jens Pietzsch
Journal:  Clin Chem Lab Med       Date:  2007       Impact factor: 3.694

8.  High plasma phospholipid transfer protein levels as a risk factor for coronary artery disease.

Authors:  Axel Schlitt; Christoph Bickel; Prathima Thumma; Stefan Blankenberg; Hans J Rupprecht; Juergen Meyer; Xian-Cheng Jiang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-08-28       Impact factor: 8.311

9.  Low phospholipid transfer protein (PLTP) is a risk factor for peripheral atherosclerosis.

Authors:  Wilfried Schgoer; Thomas Mueller; Matti Jauhiainen; Andreas Wehinger; Roland Gander; Ivan Tancevski; Karin Salzmann; Philipp Eller; Andreas Ritsch; Meinhard Haltmayer; Christian Ehnholm; Josef R Patsch; Bernhard Foeger
Journal:  Atherosclerosis       Date:  2007-06-05       Impact factor: 5.162

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

View more
  1 in total

1.  Acute effects of dietary fat on inflammatory markers and gene expression in first-degree relatives of type 2 diabetes patients.

Authors:  Anna Pietraszek; Søren Gregersen; Kjeld Hermansen
Journal:  Rev Diabet Stud       Date:  2012-02-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.